Pre-order Enquiry
Request Free Sample
Herpes Simplex -Epidemiology Forecast to 2028
SKU ID : DEL-13733877 | Publishing Date : 01-Jan-2019 | No. of pages : 50
Request Sample
Request Customization
Check DiscountsDetailed TOC of Herpes Simplex -Epidemiology Forecast to 2028
1. Key Insights2. Disease Background and Overview: Herpes Simplex Virus (HSV)
2.1. Introduction
2.2. Stages of Herpes infection
2.3. Clinical manifestations
2.4. Risk Factors
2.5. Disease Causes
2.6. HSV-Symptoms
2.7. Pathogenesis
2.8. HSV Diagnosis
3. Epidemiology and Patient Population
4. Key Findings
4.1. Disease Definition
4.2. Population and Forecast Parameters
4.3. 7MM Prevalent Population of Herpes Simplex Virus (HSV)
4.4. 7MM Type-Specific Prevalent Population of Herpes Simplex Virus (HSV)
5. Country Wise-Epidemiology of Herpes Simplex Virus (HSV)
5.1. United States
5.1.1. Prevalent Population of HSV in the United States
5.1.2. Type-Specific HSV Prevalence in the United States
5.1.3. Diagnosed Cases of HSV in the United States
5.2. Germany
5.2.1. Prevalent Population of HSV in Germany
5.2.2. Type-Specific HSV Prevalence in Germany
5.2.3. Diagnosed Cases of HSV in Germany
5.3. France
5.3.1. Prevalent Population of HSV in France
5.3.2. Type-Specific HSV Prevalence in France
5.3.3. Diagnosed Cases of HSV in France
5.4. Italy
5.4.1. Prevalent Population of HSV in Italy
5.4.2. Type Specific HSV prevalence in Italy
5.4.3. Diagnosed cases of HSV in Italy
5.5. Spain
5.5.1. Prevalent Population of HSV in Spain
5.5.2. Type Specific HSV prevalence in Spain
5.5.3. Diagnosed cases of HSV in Spain
5.6. United Kingdom
5.6.1. Prevalent cases of HSV in the UK
5.6.2. Type Specific HSV prevalence in the UK
5.6.3. Diagnosed cases of HSV in the UK
5.7. Japan
5.7.1. Prevalent cases of HSV in Japan
5.7.2. Type Specific HSV prevalence in Japan
5.7.3. Diagnosed cases of HSV in Japan
6. Market Drivers of HSV
7. Market Barriers of HSV
8. Appendix
9. Report Methodology
9.1. Sources Used
10. Capabilities
11. Disclaimer
12. About
List of Figures, Tables and Charts Available in Herpes Simplex -Epidemiology Forecast to 2028
Table 1: Prevalent Population of HSV in the 7MM (2016-2028)Table 2: 7MM Type-Specific Prevalent Population of HSV (2016-2028)
Table 3: Prevalent Population of HSV in the United States (2016-2028)
Table 4: Type-Specific HSV Prevalence in the United States (2016-2028)
Table 5: Diagnosed Cases of HSV in the United States (2016-2028)
Table 6: Prevalent Population of HSV in Germany (2016-2028)
Table 7: Type-Specific HSV Prevalence in Germany (2016-2028)
Table 8: Diagnosed Cases of HSV in Germany (2016-2028)
Table 9: Prevalent Population of HSV in France (2016-2028)
Table 10: Type-Specific HSV Prevalence in France (2016-2028)
Table 11: Diagnosed Cases of HSV in France (2016-2028)
Table 12: Prevalent Population of HSV in Italy (2016-2028)
Table 13: Type-Specific HSV Prevalence in Italy (2016-2028)
Table 14: Diagnosed Cases of HSV in Italy (2016-2028)
Table 15: Prevalent Population of HSV in Spain (2016-2028)
Table 16: Type-Specific HSV Prevalence in Spain (2016-2028)
Table 17: Diagnosed Cases of HSV in Spain (2016-2028)
Table 18: Prevalent Population of HSV in the UK (2016-2028)
Table 19: Type-Specific HSV Prevalence in the UK (2016-2028)
Table 20: Diagnosed Cases of HSV in the UK (2016-2028)
Table 21: Prevalent Population of HSV in Japan (2016-2028)
Table 22: Type-Specific HSV Prevalence in Japan (2016-2028)
Table 23: Diagnosed Cases of HSV in Japan (2016-2028)
Figure 1: Stages of Herpes infection
Figure 2: Clinical manifestations of Herpes infection
Figure 3: Risk factors associated with Herpes Simplex
Figure 4: Blisters
Figure 5: (a) Primary infection (b) Recurrent infection
Figure 6: Life Cycle of HSV infection
Figure 7: Establishment of primary infection
Figure 8: Prevalent Population of HSV in the 7MM (2016-2028)
Figure 9: 7MM Type-Specific Prevalent Population of HSV (2016-2028)
Figure 10: Prevalent Population of HSV in the United States (2016-2028)
Figure 11: Type-specific HSV Prevalence in the United States (2016-2028)
Figure 12: Diagnosed Cases of HSV in the United States (2016-2028)
Figure 13: Prevalent Population of HSV in Germany (2016-2028)
Figure 14: Type-specific HSV Prevalence in Germany (2016-2028)
Figure 15: Diagnosed Cases of HSV in Germany (2016-2028)
Figure 16: Prevalent Population of HSV in France (2016-2028)
Figure 17: Type-specific HSV Prevalence in France (2016-2028)
Figure 18: Diagnosed Cases of HSV in France (2016-2028)
Figure 19: Prevalent Population of HSV in Italy (2016-2028)
Figure 20: Type-specific HSV Prevalence in Italy (2016-2028)
Figure 21: Diagnosed Cases of HSV in Italy (2016-2028)
Figure 22: Prevalent Population of HSV in Spain (2016-2028)
Figure 23: Type-specific HSV Prevalence in Spain (2016-2028)
Figure 24: Diagnosed Cases of HSV in Spain (2016-2028)
Figure 25: Prevalent Population of HSV in the UK (2016-2028)
Figure 26: Type-specific HSV Prevalence in the UK (2016-2028)
Figure 27: Diagnosed Cases of HSV in the UK (2016-2028)
Figure 28: Prevalent Population of HSV in Japan (2016-2028)
Figure 29: Type-specific HSV Prevalence in Japan (2016-2028)
Figure 30: Diagnosed Cases of HSV in Japan (2016-2028)
